MYCN and neuroblastoma: Given the critical role played by LRP8 and the selenocysteine metabolism in preventing ferroptosis in highly aggressive neuroblastoma subtypes with MYCN amplifications, we addressed whether LRP8 elimination could target neuroblastoma growth by inducing ferroptosis in vivo.